Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells

Overview of attention for article published in Oncogene, April 2004

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 25 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

CaMKK-β as a target for treating cancer

Grant US-9999620-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.